Prospects for glycerol-rescued hypoglycemia as a cancer therapy

Medical Hypotheses

Volumn 56, Issue 3, 2001, Pages 286-289

  McCarty, M F ^a  

^a Pantox Laboratories   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

3 MERCAPTOPICOLINIC ACID; 5 AMINO 4 IMIDAZOLECARBOXAMIDE; FRUCTOSE BISPHOSPHATASE; GLUCOSE 6 PHOSPHATASE; GLYCEROL; INSULIN; MANNITOL;

ARTICLE; CANCER THERAPY; GLUCONEOGENESIS; GLUCOSE BLOOD LEVEL; GLUCOSE TRANSPORT; GLYCOLYSIS; HUMAN; HYPOGLYCEMIA; MUSCLE METABOLISM; PRIORITY JOURNAL;

EID: 0035041418     PISSN: 03069877     EISSN: None     Source Type: Journal    
DOI: 10.1054/mehy.2000.1156     Document Type: Article

References (34)

1. Glucose consumption by transplanted tumors in vivo
2. Tumor eradication by radiofrequency therapy. Responses in 21 patients
3. The interstitial fluid of solid tumors
4. On the amount and significance of the effective glucose level in tumors. A contribution to the theory of cancer
5. Selective potentiation of hyperthermic killing of hypoxic cells by 5-thio-D-glucose
6. Preferential killing of glucose-depleted HeLa cells by menadione and hyperthermia
7. Hypoglycemia with glycerol infusion as antineoplastic therapy: A hypothesis
8. Hypoglycemia with glycerol salvage: A role in anti-neoplastic therapy?
9. Proportional activities of glycerol kinase and glycerol 3-phosphate dehydrogenase in rat hepatomas
10. Low levels of soluble DPN-linked aglycerophosphate dehydrogenase in tumors
11. Glycerol utilization and its regulation in mammals
12. Glycerol as a substrate for brain metabolism
13. Studies on the metabolism of glycerol by small intestine in vitro and in vivo
14. Effect of 3-mercaptopicolinic acid on gluconeogenesis and gluconeogenic metabolite concentrations in the isolated perfused rat liver
15. Mechanism of 3-mercaptopicolinic acid inhibition of hepatic phosphoenolpyruvate carboxykinase (GTP)
16. Chlorogenic acid and synthetic chlorogenic acid derivatives: Novel inhibitors of hepatic glucose-6-phosphate translocase
17. Chlorogenic acid and hydroxynitrobenzaldehyde: New inhibitors of hepatic glucose 6-phosphatase
18. Pharmacodynamic profile of a novel inhibitor of the hepatic glucose-6-phosphatase system
19. Plasma glucose levels are reduced in rats and mice treated with an inhibitor of glucose-6-phosphate translocase
20. Vanadate: A potent inhibitor of multifunctional glucose-6-phosphatase
21. Time-dependent inhibition of glucose 6-phosphatase by 3-mercaptopicolinic acid
22. Inhibition of gluconeogenesis by tolbutamide in isolated rat hepatocytes: Modulation of glucose-6-phosphate substrate cycle
23. Inhibition by AICA riboside of gluconeogenesis in isolated rat hepatocytes
24. AICA riboside improves myocardial ischemia in coronary microembolization in dogs
25. Timely administration of AICA riboside reduces reperfusion injury in rabbits
26. AICA-riboside: Safety, tolerance, and pharmacokinetics of a novel adenosine-regulating agent
27. Inhibition of gluconeogenesis and glycogenolysis by 2,5-anhydro-D-mannitol
28. Differential hypoglycemic effect of 2,5-anhydro-D-mannitol, a putative gluconeogenesis inhibitor, in genetically diabetic (db/db) and streptozotocin-induced diabetic mice
29. Central role for phosphatidylinositide 3-kinase in the repression of glucose-6-phosphatase gene transcription by insulin
30. cDNA sequence of rat liver fructose-1,6-bisphosphatase and evidence for down-regulation of its mRNA by insulin
31. cAMP-independent synergistic effects of insulin and dexamethasone on fructose 2,6-bisphosphate metabolism in H41IE cells
32. Fructose-2,6-bisphosphate in control of hepatic glyconeogenesis. From metabolites to molecular genetics
33. Induction of rat liver 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase mRNA by refeeding and insulin